Studies early life experiences and sickle cell disease in adults
Tests a breastfeeding support group in adults with sickle cell disease.
Key facts
- Who runs it
- University of Alabama at Birmingham
- Where
- Birmingham, United StatesSee the site
- Trial code
- Registry title
- Early Life Exposures Among Children With Sickle Cell Disease
- Status
- Recruiting
- People taking part
- 20 people, planned
- Started
- 1 Aug 2026
- Expected to end
- 31 Dec 2027
- Type of study
- Interventional, 2 groups
- Treatments tested
- Breastfeeding support group
- Observation
- Record updated
- 15 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for mothers of infants with sickle cell disease who live in or near Birmingham, Alabama. It studies early life exposures, such as breastfeeding and adverse childhood experiences.
- Age
- 18 to 50 years
- Sex
- Women only
- Disease stage
- The mother's infant has sickle cell disease.
- Earlier treatment
- Mothers who are prescribed teratogenic medications cannot join.
Main reasons for not taking part
- Prescribed teratogenic medications
- No or limited internet access
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- mother of infant with sickle cell disease
- resides within the city of Birmingham, Alabama or in close proximity
Who cannot take part
- prescribed teratogenic medications
- no/limited internet access
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 50 years old?
Where in United States
- University of Alabama at BirminghamBirmingham, United StatesContact: Brandi M Pernell, DNP, MSPHTaking people
About the trial
What the trial wants to find out
This study is being conducted to determine the relationship between early childhood exposures, such as Adverse Childhood Experiences, Social Determinants of Health and nutrition/breastfeeding, among children with sickle cell disease, and behavioral interventions aimed to reshape psychological resilience and lifestyle factors towards positive health outcomes.
The 2 groups in the trial
- Breastfeeding Intervention GroupTreatment being tested
Ten mother-infant dyads will be recruited to a six-month, community-based intervention aimed to promote sustained breastfeeding for at least six months among mothers of infants with sickle cell disease. The intervention will include an online, social media-based support group, online educational modules, monthly in-person educational sessions, access to free breast pump rentals, and monthly peer-led home visits by certified Vanderbilt-affiliated Maternal Infant Health Outreach Specialists. We obtain whole blood specimens for analysis of oxidative stress and inflammation at 3, 6, 12 and 24 months.
Treatment: Breastfeeding support group
- Observation GroupOther group
A 24 month observation of 10 mother-infant dyads affected by sickle cell disease that initiate breastfeeding. These dyads will observed for breastfeeding exclusivity/dosage and duration. We obtain whole blood specimens for analysis of oxidative stress and inflammation at 3, 6, 12 and 24 months.
Treatment: Observation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Early Life Exposures Among Children With Sickle Cell Disease
- Plain-language title
- Studies early life experiences and sickle cell disease in adultsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT05377372, who can take part
- Record updated
- 15 July 2026